Newsletter

Cancer Globally (Vol. 1, Issue 1)
How is cancer market evolving globally with the launch of upcoming therapies in the near future?
CANCER GLOBALLY (VOL. 1, ISSUE 1)

More Whitepapers / Newsletters

Car-T Cell Therapy: A Journey From Challenges To Opportunities
Car-T Cell Therapy: A Journey...

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age of cancer. Immunotherapy can be taken as a very powerful tool that can alter the immune system's pi...

Alzheimer's disease
Alzheimer's disease

Alzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroys memory and thinking skills of an individual. It is the most common cause of dementia (a continuous...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...

Warm Autoimmune Hemolytic Anemia
Warm Autoimmune Hemolytic Anem...

Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfunction in the immune system in which the immune system attacks its red blood cells considering them f...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...